YD Bio Ltd SEC filings YDES
YD Bio Ltd has 80 filings in SEC EDGAR's recent list, going back to Feb 14, 2024. Its latest annual report, Form 20-F, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Sep 1, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 424B3 | Prospectus | Sep 1, 2026 | — |
| 424B3 | Prospectus | Aug 11, 2026 | — |
| POS AM | Post-effective amendment no. 1 to form f-1 | May 26, 2026 | — |
| 424B3 | Prospectus | Feb 27, 2026 | — |
| 424B3 | Prospectus | Feb 5, 2026 | — |
| S-8 | Employee stock plan registration | Jan 2, 2026 | — |
| 424B3 | Prospectus | Nov 17, 2025 | — |
| F-1/A | Amendment no. 1 to form f-1 | Oct 24, 2025 | — |
| F-1 | Registration statement (foreign issuer) | Sep 23, 2025 | — |
| 424B3 | Prospectus | Jul 18, 2025 | — |
| F-4/A | Registration statement | Jul 16, 2025 | — |
| F-4/A | Registration statement | Jul 10, 2025 | — |
| F-4/A | Registration statement | Jul 7, 2025 | — |
| F-4/A | Registration statement | Jun 30, 2025 | — |
| F-4/A | Registration statement | Jun 5, 2025 | — |
| F-4/A | Registration statement | Apr 30, 2025 | — |
| F-4/A | Registration statement | Mar 17, 2025 | — |
| F-4/A | Registration statement | Jan 30, 2025 | — |
| F-4/A | Registration statement | Dec 20, 2024 | — |
| F-4/A | Registration statement | Dec 17, 2024 | — |
| F-4 | Registration statement | Nov 25, 2024 | — |
| S-4 | Registration for a merger or exchange | Feb 14, 2024 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- YDES (Nasdaq), YDESW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Cayman Islands
- Headquarters
- Taipei City
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 2011674
- Former names
- True Velocity, Inc./DE (until Jun 21, 2024)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.